141 related articles for article (PubMed ID: 30552693)
41. Identification and comparison of long non-conding RNA in Jinhua and Landrace pigs.
Miao Z; Wang S; Zhang J; Wei P; Guo L; Liu D; Wang Y; Shi M
Biochem Biophys Res Commun; 2018 Nov; 506(3):765-771. PubMed ID: 29890140
[TBL] [Abstract][Full Text] [Related]
42. Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer.
Peng WX; Huang JG; Yang L; Gong AH; Mo YY
Mol Cancer; 2017 Oct; 16(1):161. PubMed ID: 29041978
[TBL] [Abstract][Full Text] [Related]
43. LncRNA SNHG14 promotes the progression of cervical cancer by regulating miR-206/YWHAZ.
Ji N; Wang Y; Bao G; Yan J; Ji S
Pathol Res Pract; 2019 Apr; 215(4):668-675. PubMed ID: 30611620
[TBL] [Abstract][Full Text] [Related]
44. Down-regulation of LncRNA NR027113 inhibits cell proliferation and metastasis via PTEN/PI3K/AKT signaling pathway in hepatocellular carcinoma.
Chen Z; Zhou ZY; He CC; Zhang JL; Wang J; Xiao ZY
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7222-7232. PubMed ID: 30468465
[TBL] [Abstract][Full Text] [Related]
45. Systematic gene microarray analysis of the lncRNA expression profiles in human uterine cervix carcinoma.
Chen J; Fu Z; Ji C; Gu P; Xu P; Yu N; Kan Y; Wu X; Shen R; Shen Y
Biomed Pharmacother; 2015 May; 72():83-90. PubMed ID: 26054679
[TBL] [Abstract][Full Text] [Related]
46. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1/microRNA-202-3p/periostin axis modulates invasion and epithelial-mesenchymal transition in human cervical cancer.
Han X; Wang Q; Wang Y; Hu B; Dong X; Zhang H; Wang W
J Cell Physiol; 2019 Aug; 234(8):14170-14180. PubMed ID: 30633360
[TBL] [Abstract][Full Text] [Related]
47. Long noncoding RNA CCHE1 indicates a poor prognosis of hepatocellular carcinoma and promotes carcinogenesis via activation of the ERK/MAPK pathway.
Peng W; Fan H
Biomed Pharmacother; 2016 Oct; 83():450-455. PubMed ID: 27427851
[TBL] [Abstract][Full Text] [Related]
48. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
He R; Wu JX; Zhang Y; Che H; Yang L
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
[TBL] [Abstract][Full Text] [Related]
49. LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathway.
Li H; Jia Y; Cheng J; Liu G; Song F
Cell Death Dis; 2018 Feb; 9(2):198. PubMed ID: 29416014
[TBL] [Abstract][Full Text] [Related]
50. Long non‑coding RNA FER1L4 inhibits cell proliferation and metastasis through regulation of the PI3K/AKT signaling pathway in lung cancer cells.
Gao X; Wang N; Wu S; Cui H; An X; Yang Y
Mol Med Rep; 2019 Jul; 20(1):182-190. PubMed ID: 31115514
[TBL] [Abstract][Full Text] [Related]
51. Modulation of cancer cell signaling by long noncoding RNAs.
Mirhosseini SA; Sarfi M; Samavarchi Tehrani S; Mirazakhani M; Maniati M; Amani J
J Cell Biochem; 2019 Aug; 120(8):12224-12246. PubMed ID: 31069841
[TBL] [Abstract][Full Text] [Related]
52. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
53. TNF-α-induced lncRNA LOC105374902 promotes the malignant behavior of cervical cancer cells by acting as a sponge of miR-1285-3p.
Feng Y; Ma J; Fan H; Liu M; Zhu Y; Li Y; Tang H
Biochem Biophys Res Commun; 2019 May; 513(1):56-63. PubMed ID: 30935691
[TBL] [Abstract][Full Text] [Related]
54. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients.
Chen X; Liu L; Zhu W
Int J Clin Exp Pathol; 2015; 8(10):13261-6. PubMed ID: 26722527
[TBL] [Abstract][Full Text] [Related]
55. LncRNA LINC00641 predicts prognosis and inhibits bladder cancer progression through miR-197-3p/KLF10/PTEN/PI3K/AKT cascade.
Li Z; Hong S; Liu Z
Biochem Biophys Res Commun; 2018 Sep; 503(3):1825-1829. PubMed ID: 30060954
[TBL] [Abstract][Full Text] [Related]
56. LncRNA MNX1-AS1 promotes the progression of cervical cancer through activating MAPK pathway.
Liu X; Yang Q; Yan J; Zhang X; Zheng M
J Cell Biochem; 2019 Mar; 120(3):4268-4277. PubMed ID: 30302806
[TBL] [Abstract][Full Text] [Related]
57. Baicalein inhibits cervical cancer progression via downregulating long noncoding RNA BDLNR and its downstream PI3K/Akt pathway.
Yu X; Yang Y; Li Y; Cao Y; Tang L; Chen F; Xia J
Int J Biochem Cell Biol; 2018 Jan; 94():107-118. PubMed ID: 29175387
[TBL] [Abstract][Full Text] [Related]
58. Role of cytoplasmic lncRNAs in regulating cancer signaling pathways.
Fu PF; Zheng X; Fan X; Lin AF
J Zhejiang Univ Sci B; 2019 Jan.; 20(1):1-8. PubMed ID: 30614225
[TBL] [Abstract][Full Text] [Related]
59. LncRNAs: key players and novel insights into cervical cancer.
Peng L; Yuan X; Jiang B; Tang Z; Li GC
Tumour Biol; 2016 Mar; 37(3):2779-88. PubMed ID: 26715267
[TBL] [Abstract][Full Text] [Related]
60. Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
Fang L; Wang H; Li P
Invest New Drugs; 2018 Apr; 36(2):187-194. PubMed ID: 29082457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
